Amy C. Peterson

Insider Reports History

Entity
Individual
Location
C/O Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands
Signature
/s/ Nina Ayer, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amy C. Peterson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXELIXIS, INC. EVP Prod Dev & Med Aff & CMO Common Stock 295K $10.3M $35.05 Nov 15, 2024 Direct
CytomX Therapeutics, Inc. EVP, Chief Development Officer Common Stock 58.4K $80.7K $1.38 Mar 16, 2023 Direct

Insider Reports Filed by Amy C. Peterson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EXEL EXELIXIS, INC. Nov 15, 2024 1 -$954K 4 Nov 19, 2024 EVP Prod Dev & Med Aff & CMO
EXEL EXELIXIS, INC. Feb 23, 2024 1 $0 4 Feb 27, 2024 EVP Prod Dev & Med Aff & CMO
EXEL EXELIXIS, INC. Aug 24, 2023 2 $0 4 Aug 25, 2023 EVP Prod Dev & Med Aff & CMO
EXEL EXELIXIS, INC. Aug 24, 2023 0 $0 3 Aug 25, 2023 EVP Prod Dev & Med Aff & CMO
CTMX CytomX Therapeutics, Inc. Mar 16, 2023 1 -$8.42K 4 Mar 20, 2023 EVP, Chief Development Officer
CTMX CytomX Therapeutics, Inc. Jul 19, 2022 2 -$10.6K 4 Jul 21, 2022 EVP, Chief Development Officer
CTMX CytomX Therapeutics, Inc. Feb 2, 2022 2 $0 4 Feb 4, 2022 EVP, Chief Development Officer
CTMX CytomX Therapeutics, Inc. Oct 24, 2021 2 $0 4 Oct 26, 2021 EVP, Chief Development Officer
CTMX CytomX Therapeutics, Inc. May 31, 2021 1 $20.2K 4 Jun 8, 2021 EVP, Chief Development Officer